{"url_path":"/sec/eltp/8-k/2026-06-29/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/1053369/0001493152-26-031103-index.html","accession_number":"0001493152-26-031103","cik":"0001053369","ticker":"ELTP","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","edgar_url":"https://www.sec.gov/Archives/edgar/data/1053369/0001493152-26-031103-index.html","primary_entity_key":"0001053369","primary_entity_name":"ELITE PHARMACEUTICALS INC /NV/"},"word_count":145,"has_tables":true,"body_markdown":"**Item\n2.02. Results of Operations and Financial Condition.**\n\n \n\nOn\nJune 29, 2026, Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) filed its year-end report on Form 10-K\nfor the fiscal year ended March 31, 2026, and, thereafter, issued a press release announcing its financial results for that fiscal year.\nA copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.\n\n \n\nAs\nnoted in the press release, the Company will host a conference call at 11:30 AM Eastern Daylight Time (EDT) on Tuesday, June 30, 2026,\nto provide a general business update. Elite will respond to various stockholder questions submitted prior to the call.\n\n \n\n**Conference\nCall Information**\n\n \n\nDate:\n\nJune\n30, 2026\n\nTime:\n\n11:30\nAM EDT\n\nDial-in\nnumbers:\n1-800-346-7359\n(domestic)\n\n \n1-973-528-0008\n(international)\n\nConference\nnumber:\n98840\n\nQuestions:\ndianne@elitepharma.com\n\n \nFinancial\nquestions by 7:00 PM EDT on Monday, June 29, 2026\n\nAudio\nReplay:\nhttps://elite.irpass.com/events_presentations"}